Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.
Journal of Clinical Oncology.
Times cited: 232
Pulmonary tumor thrombotic microangiopathy: An often missed antemortem diagnosis.
Archives of Pathology and Laboratory Medicine.
Times cited: 22